Relay Therapeutics, Inc. (RLAY) Tops Q2 EPS by 4c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q2 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Our Bond (OBAI) files for 10M share offering by selling stockholders
• Hyperscale Data declares preferred stock dividends for August